Scientific research analysis
-
Overreliance on TSH is a thyroid therapy policy that fails to detect its own failure
In standard T4 thyroid therapy, TSH normalization is so easy to achieve that it is almost impossible to fail. First, TSH out of range is the judge of an initial DIAGNOSIS. Next, normal TSH becomes the sole TARGET of therapy. Finally, normal TSH becomes the sole JUDGE of therapy success. This is faulty reasoning. There…
-
Targeting TSH? It’s not as specific or as sensitive as people claim.
Patients and doctors are often told there’s an ideal “target” for TSH levels. Some believe that in thyroid therapy, your TSH should be below the upper reference limit, some say it should be below 2.5, and a minority will even say it should be suppressed entirely whether or not you are a thyroid cancer patient.…
-
The mini-T3-mono-combination therapy model vs NDT and others
I’d like to talk about contemporary researchers’ rigid and limited approach to combination therapy. This is the model whose many limitations I point out with the ridiculously long label “mini-T3-mono-combination” therapy. I’ll go over some of the history behind this model, the source of the rigid ratios that we learned about in our series on…
-
Low T3 syndrome in thyroid therapy: THREE studies
In contrast with a long list of over 70 medical research articles on low T3 syndrome that excluded thyroid patients, I have only found three (3) studies so far that included patients being treated for hypothyroidism. I’ll reveal their treasures and disappointments in reverse date order: Somppi, 2017 Tevaarwerk, 2014 Wadwekar, 2004 Here’s how many…
-
Thyroid patients are routinely excluded from low T3 syndrome (NTIS) research
Most studies of Low T3 syndrome (NTIS) routinely EXCLUDE thyroid patients. Sadly, our exclusion has become a research tradition. In this post, I lay out the landscape and extent of our exclusion from this valuable area of thyroid hormone health research. Everyone loses by our exclusion. Especially thyroid patients. Everyone has something to gain from…